| Peer-Reviewed

Serological Detection of Helicobacter pylori Antibodies in Patients Suffering from Gastric Symptoms in Kano, Nigeria

Received: 31 August 2015    Accepted: 16 September 2015    Published: 17 November 2015
Views:       Downloads:
Abstract

Background: Helicobacter pylori is a major gastroduodenal pathogen and its seropositivity is associated with increased risk of development of human active chronic gastritis, peptic and duodenal ulcer and gastric cancer. Objectives: The aim of this study was to determine the seroprevalence of H. pylori infection among subjects with gastrointestinal problems. Methods: From May 2014 to October 2014, a seroprevalence study was carried out among 100 subjects who had clinical gastric symptoms, with a mean age of 37.77 years (range, 2 to 70 years). Serum samples collected from 44 male and 56 female were screened for detection of anti H. pylori IgG using commercial DIAQUICK Helicobacter pylori (manufactured by DIALAB Production, GMBH) kit. Statistical analyses were performed using SAS software, version 9.1 (SAS Institute Inc., Cary, NC). Results: The overall seropositivity rate of anti H. pylori IgG was 53%. Seropositivity of anti H. pylori IgG increased markedly with age and highest infection rate (96%) was seen in individuals 40 to 50 years old. Anti H. pylori IgA was also correlated with increasing age. Analysis of results for gender showed that there were no significant differences in seropositivity to H. pylori between men and woman (p>0.05) but there was a significant correlation between anti H. pylori IgG and age of subjects (p<0.01). Analysis of results for inflammatory markers (WBC and ESR) showed normal mean of WBC count(7000 cells/ml) and ESR rate (8mm/h) levels in these subjects. No association was detected between H. pylori seropositivity, gender and inflammatory laboratory parameters. Conclusion: This study revealed the high prevalence of H. pylori infection among symptomatic subjects in the study area suggesting necessity of screening for H. pylori infection in symptomatic patients. The results also did not show any strict relations between H. pylori seropositivity, gender and inflammatory markers.

Published in American Journal of Health Research (Volume 3, Issue 6)
DOI 10.11648/j.ajhr.20150306.16
Page(s) 352-355
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Helicobacter pylori, Seroprevalence, IgG, Gastritis, Nigeria

References
[1] Alborzi A, Soltani J, Pourabbas B, Oboodi B, Haghighat M, Hayati M, Rashidi M (2006). Prevalence of Helicobacter pylori infection in children (south of Iran). Diagn. Microbiol. Infect. Dis. 54: 259-261.
[2] Atalay C, Atalay G, Altinok M (2003). Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.Neoplasma50: 185-190.
[3] Best LM, Veldhuyzen van Zanten SJ, Sherman PM, Bezanson GS (1994). Serological detection of Helicobacter pylori antibodies in children and their parents. J. Clin. Microbiol.32(5): 1193-1196.
[4] Fock KM (1997). Helicobacter pylori infection - Current status in Singapore. Ann. Acad. Med. Singapore 26(5): 637-641.
[5] Gdalevich M, Cohen D, Ashkenazi I, Mimouni D, Shpilberg O, Kark JD (2000). Helicobacter pylori infection and subsequent peptic duodenal disease among young adults. Int. J. Epidemiol. 29: 592-595.
[6] Gill HH, Majmudar P, Shankaran K, Desai HG (1994). Age-related prevalence of Helicobacter pylori antibodies in Indian subjects. Indian J. Gastroenterol.13: 92-94.
[7] Gisbert JP, Pajares JM (2001). Diagnosis of Helicobacter pylori infection by stool antigen determination: A systematic review. Am. J. Gastroenterol. 96: 2829-2838.
[8] Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E (1991). Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: Effect on age, race, and socioeconomic status. Gastroenterology100: 1495-1501.
[9] Ifeanyi OCO and Prosper OUA (2013). Prevalence of Helicobacter pylori and other intestinal parasites amongst duodenal and gastric ulcer patients at Imo state University Teaching Hospital, Orlu, South-eastern Nigeria. Journal of Medicine and Medical Sciences. 4(9): 362-369 Available online http://www.interesjournals.org/JMMS.
[10] Jafarzadeh A, Rezayati MT, Nemati M (2007).Specific serum immunoglobulin G to H. pylori and CagA in healthy children and adults (south-east of Iran).World J. Gastroenterol.13: 3117-3121.
[11] Jimenez-Guerra F, Shetty P, Kurpad A (2000).Prevalence of and risk factors for helicobacter pylori infection in school children in Mexico.Ann. Epidemiol. 10: 474.
[12] Kate V, Ananthakrishnan N, Ratnakar C, Badrinath S (2001). Anti - H. pylori IgG seroprevalence rates in asymptomatic children and adults from South India. Indian J. Med. Microbiol.19: 20-25.
[13] Leandro Liberato SV, Hernndez Galindo M, Torroba Alvarez L, SmezAbada A, ChuecaRodrguez P (2005). Helicobacter pylori infection in the child population in Spain: Prevalence, related factors and influence on growth. An. Pediatr. (Barc) 63: 489-494.
[14] Lindkvist P, Asrat D, Nilsson I, Tsega E, Olsson GL, Wretlind B, Giesecke J (1996). Age at acquisition of Helicobacter pylori infection: Comparison of a high and a low prevalence country. Scand. J. Infect. Dis.28: 181-184.
[15] Mahalanabis D, Rahman MM, Sarker SA, Bardhan PK, Hildebrand P, Beglinger C, Gyr K (1996). Helicobacter pylori infection in the young in Bangladesh: Prevalence, socioeconomic and nutritional aspects. Int. J. Epidemiol.25: 894-898.
[16] Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: Epidemiology and risk factors. Arch. Iran Med.12: 576-583.
[17] Marshall BJ, McGechie DB, Rogers PAR and Glancy RG (1985).Pyloric Camylobacter infection and gastroduodenal disease. Med. J Australia.149:439-44.
[18] Nouraie M, Latifi-Navid S, Rezvan H, Radmard AR, Maghsudlu M, Zaer-Rezaii H, Amini S, Siavoshi F, Malekzadeh R (2009). Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter14: 40-46.
[19] Oluwasola AO, Ola SO, Saliu L, Solanke TF (2002).Helicobacter pylori infection in South Nigerians: A serological study of dyspeptic patients and healthy individuals. West Afr. J. Med. 21: 138-141.
[20] Olufemi FO, Quadri R, Akinduti PA and Bamiro SA(2015) Potential Risk Factors and Prevalence of Infection of Helicobacter pylori in Nigeria. Journal of Scientific Research & Reports. 7(1): 42-48.
[21] Pérez-Pérez GI, Cutler AF, Blaser MJ (1997).Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin. Infect. Dis. 25: 1038-1043.
[22] Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L (2000) Helicobacter pylori-related disease: Guidelines for testing and treatment. Arch. Int. Med.160: 1285-1291.
[23] Ricci C, Holton J, Vaira D (2007). Diagnosis of Helicobacter pylori: Invasive and non-invasive tests. Best Pract. Res. Clin. Gastroenterol.21: 299-313.
[24] Seher C, Thierfelder W, Dortschy R (2000). Helicobacter pylori-prevalence in the German population. Gesundheitswesen62: 598–603.
[25] Soll AH (1990). Pathogenesis of peptic ulcer and implications for therapy. New England J. Med.322:909-16.
[26] Suerbaum S, Michetti P (2002). Helicobacter pylori infection.N. Engl. J. Med. 347: 1175-1186.
[27] Torres J, Pérez-Pérez G, Goodman KJ, Atherton JC, Gold BD, Harris oz O (2000). A comprehensive review of the natural history of Helicobacter pylori infection in children. Arch. Med. Res. 31: 431-469.
Cite This Article
  • APA Style

    Abdulhadi Sale Kumurya. (2015). Serological Detection of Helicobacter pylori Antibodies in Patients Suffering from Gastric Symptoms in Kano, Nigeria. American Journal of Health Research, 3(6), 352-355. https://doi.org/10.11648/j.ajhr.20150306.16

    Copy | Download

    ACS Style

    Abdulhadi Sale Kumurya. Serological Detection of Helicobacter pylori Antibodies in Patients Suffering from Gastric Symptoms in Kano, Nigeria. Am. J. Health Res. 2015, 3(6), 352-355. doi: 10.11648/j.ajhr.20150306.16

    Copy | Download

    AMA Style

    Abdulhadi Sale Kumurya. Serological Detection of Helicobacter pylori Antibodies in Patients Suffering from Gastric Symptoms in Kano, Nigeria. Am J Health Res. 2015;3(6):352-355. doi: 10.11648/j.ajhr.20150306.16

    Copy | Download

  • @article{10.11648/j.ajhr.20150306.16,
      author = {Abdulhadi Sale Kumurya},
      title = {Serological Detection of Helicobacter pylori Antibodies in Patients Suffering from Gastric Symptoms in Kano, Nigeria},
      journal = {American Journal of Health Research},
      volume = {3},
      number = {6},
      pages = {352-355},
      doi = {10.11648/j.ajhr.20150306.16},
      url = {https://doi.org/10.11648/j.ajhr.20150306.16},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20150306.16},
      abstract = {Background: Helicobacter pylori is a major gastroduodenal pathogen and its seropositivity is associated with increased risk of development of human active chronic gastritis, peptic and duodenal ulcer and gastric cancer. Objectives: The aim of this study was to determine the seroprevalence of H. pylori infection among subjects with gastrointestinal problems. Methods: From May 2014 to October 2014, a seroprevalence study was carried out among 100 subjects who had clinical gastric symptoms, with a mean age of 37.77 years (range, 2 to 70 years). Serum samples collected from 44 male and 56 female were screened for detection of anti H. pylori IgG using commercial DIAQUICK Helicobacter pylori (manufactured by DIALAB Production, GMBH) kit. Statistical analyses were performed using SAS software, version 9.1 (SAS Institute Inc., Cary, NC). Results: The overall seropositivity rate of anti H. pylori IgG was 53%. Seropositivity of anti H. pylori IgG increased markedly with age and highest infection rate (96%) was seen in individuals 40 to 50 years old. Anti H. pylori IgA was also correlated with increasing age. Analysis of results for gender showed that there were no significant differences in seropositivity to H. pylori between men and woman (p>0.05) but there was a significant correlation between anti H. pylori IgG and age of subjects (pH. pylori seropositivity, gender and inflammatory laboratory parameters. Conclusion: This study revealed the high prevalence of H. pylori infection among symptomatic subjects in the study area suggesting necessity of screening for H. pylori infection in symptomatic patients. The results also did not show any strict relations between H. pylori seropositivity, gender and inflammatory markers.},
     year = {2015}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Serological Detection of Helicobacter pylori Antibodies in Patients Suffering from Gastric Symptoms in Kano, Nigeria
    AU  - Abdulhadi Sale Kumurya
    Y1  - 2015/11/17
    PY  - 2015
    N1  - https://doi.org/10.11648/j.ajhr.20150306.16
    DO  - 10.11648/j.ajhr.20150306.16
    T2  - American Journal of Health Research
    JF  - American Journal of Health Research
    JO  - American Journal of Health Research
    SP  - 352
    EP  - 355
    PB  - Science Publishing Group
    SN  - 2330-8796
    UR  - https://doi.org/10.11648/j.ajhr.20150306.16
    AB  - Background: Helicobacter pylori is a major gastroduodenal pathogen and its seropositivity is associated with increased risk of development of human active chronic gastritis, peptic and duodenal ulcer and gastric cancer. Objectives: The aim of this study was to determine the seroprevalence of H. pylori infection among subjects with gastrointestinal problems. Methods: From May 2014 to October 2014, a seroprevalence study was carried out among 100 subjects who had clinical gastric symptoms, with a mean age of 37.77 years (range, 2 to 70 years). Serum samples collected from 44 male and 56 female were screened for detection of anti H. pylori IgG using commercial DIAQUICK Helicobacter pylori (manufactured by DIALAB Production, GMBH) kit. Statistical analyses were performed using SAS software, version 9.1 (SAS Institute Inc., Cary, NC). Results: The overall seropositivity rate of anti H. pylori IgG was 53%. Seropositivity of anti H. pylori IgG increased markedly with age and highest infection rate (96%) was seen in individuals 40 to 50 years old. Anti H. pylori IgA was also correlated with increasing age. Analysis of results for gender showed that there were no significant differences in seropositivity to H. pylori between men and woman (p>0.05) but there was a significant correlation between anti H. pylori IgG and age of subjects (pH. pylori seropositivity, gender and inflammatory laboratory parameters. Conclusion: This study revealed the high prevalence of H. pylori infection among symptomatic subjects in the study area suggesting necessity of screening for H. pylori infection in symptomatic patients. The results also did not show any strict relations between H. pylori seropositivity, gender and inflammatory markers.
    VL  - 3
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Bayero University, Kano, Nigeria

  • Sections